Clinical Scorecard: Consensus Guidelines for Managing Inflammatory Bowel Disease in Low- and Middle-Income Nations
At a Glance
Category
Detail
Condition
Inflammatory Bowel Disease (IBD)
Key Mechanisms
Chronic inflammatory condition of the gastrointestinal tract with increasing incidence linked to urbanization and lifestyle changes
Target Population
Patients with IBD in low- and middle-income countries (LMICs)
Care Setting
Resource-limited healthcare settings in LMICs including primary, secondary, and tertiary care with limited access to advanced diagnostics and therapies
Key Highlights
IBD incidence and prevalence are rising significantly in LMICs, paralleling trends seen in high-income countries.
Diagnosis is complicated by limited resources and frequent infectious disease mimics such as gastrointestinal tuberculosis and amoebiasis.
Management challenges include delayed diagnosis, limited access to advanced medical therapies, and higher rates of emergency surgical interventions with increased postoperative complications.
Guideline-Based Recommendations
Diagnosis
Increase awareness among healthcare professionals and the public to promote early recognition of IBD.
Utilize available diagnostic modalities while considering differential diagnoses common in LMICs such as gastrointestinal tuberculosis and amoebiasis.
Adapt diagnostic approaches to resource availability rather than relying solely on guidelines developed for high-income countries.
Management
Implement multidisciplinary care tailored to resource constraints in LMICs.
Prioritize timely medical therapy to prevent disease progression and reduce need for emergency surgery.
Enhance surgical training and access to appropriate technologies to improve outcomes of necessary surgical interventions.
Monitoring & Follow-up
Regular follow-up to monitor disease activity and treatment response within the limitations of local healthcare infrastructure.
Monitor for complications related to delayed diagnosis and advanced disease presentation.
Risks
High risk of misdiagnosis due to infectious disease mimics.
Increased postoperative complications and mortality due to emergency surgeries performed in resource-limited settings.
Potential underreporting and fragmented epidemiological data complicate disease burden assessment.
Patient & Prescribing Data
Patients with IBD in LMICs facing limited access to advanced therapies and specialist care
Treatment strategies must be adapted to local resource availability; delayed diagnosis often leads to increased surgical interventions; access to advanced medical therapies remains limited, necessitating pragmatic and multidisciplinary approaches.
Clinical Best Practices
Promote education and awareness programs targeting both healthcare providers and patients to improve early diagnosis.
Develop locally adapted diagnostic and treatment protocols reflecting resource availability and prevalent infectious mimics.
Strengthen multidisciplinary teams including gastroenterologists, surgeons, pathologists, and radiologists to optimize patient outcomes.
Encourage research focused on epidemiology and management needs specific to LMICs to guide resource allocation.
Improve surgical capacity and postoperative care to reduce morbidity and mortality associated with emergency IBD surgeries.
by Alaa El-Hussuna, Almuthe Christina Hauer, Tarkan Karakan, Valerie Pittet, Henit Yanai, Jalpa Devi, Jesus K Yamamoto-Furusho, Ali Reza Sima, Hailemichael Desalegn, Mutaz Idrees Sultan, Vishal Sharma, Hany Shehab, Lamya Mrabti, Natalia Queiroz, Anuraag Jena, Andy Darma, Karin Davidson, Nicolas Avellaneda, Muhammed Elhadi, April Roslani, Dakshitha Wickramasinghe, Carlo Angelo Cajucom, Shaji Sebastian
